10x Genomics to Participate in Morgan Stanley Global Healthcare Conference

10x Genomics will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025. The company's management team will engage in a fireside chat at 11:30 a.m. Eastern Time. The live webcast will be available on the company's investor relations website, with replay access for 30 days after the event.

10x Genomics, Inc. (Nasdaq: TXG), a leading provider in single cell and spatial biology, has announced its participation in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference. The event is scheduled for September 10, 2025, with a fireside chat featuring members of the company's management team at 11:30 a.m. Eastern Time.

The fireside chat will provide investors and interested parties with an opportunity to gain insights into the company's latest developments and future plans. The live webcast of the event will be accessible on the company's investor relations website, with a replay option available for at least 30 days following the event.

10x Genomics is a life science technology company that specializes in integrated research solutions for single cell and spatial biology. Their products have been instrumental in breakthroughs across various fields, including oncology, immunology, and neuroscience, contributing to a deeper understanding of health and disease.

For more information, investors can visit the company's website at 10xgenomics.com or connect with them on their social media platforms.

References:
[1] https://www.marketscreener.com/news/10x-genomics-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference-ce7c50ded180f127
[2] https://www.stocktitan.net/news/TXG/10x-genomics-to-participate-in-the-morgan-stanley-23rd-annual-global-iyf61rdmz8gk.html